Express Healthcare
Home  »  News  »  HCG launches Radixact X9 – new gen TomoTherapy in Kolkata

HCG launches Radixact X9 – new gen TomoTherapy in Kolkata

207

HCG EKO cancer centre becomes first hospital in India to treat patients using the Radixact X9 – the new generation TomoTherapy

HealthCare Global Enterprises (HCG) brings first Radixact X9 – the new generation TomoTherapy in India to treat cancer patients. The Radixact System is being used at HCG EKO cancer centre, a partnership between HCG and EKO X-Ray & Imaging Institute.

Dr BS Ajaikumar, Chairman & CEO, Healthcare Global Enterprises (HCG) Enterprises said, “Introducing the Radixact in Kolkata is to ensure that advance care is accessible by the patients of West Bengal and the neighboring states, and they don’t have to travel to far off locations, away from their home and close ones for cancer treatment.”

Dr Ayan Basu, Head of Radiation Oncology, HCG EKO Cancer Centre said, “Radixact now enables us to accurately deliver higher doses incorporating functional imaging like PET, improving chances of cure. The addition of India’s first Radixact X9 – the new generation TomoTherapy to HCG EKO gives our patients and radiotherapy team several key advantages: quick, accurate, daily CT scan guided, adaptable, highly conformal radiotherapy which gives the oncologist confidence to accurately treat all sites and cancer types. To share an instance, the inbuilt CT scan imaging in a Radixact system allows treating Bone Marrow Transplant patients accurately to the complete bone marrow instead of exposing all internal organs. One of the unique advantages of the system is for children with medulloblastoma (which constitutes one fifth of all childhood brain tumors), where the child can comfortably lie on his/her back and the radiation beam treats more than three times the length possible in regular machines in a single movement of the treatment couch. Radixact is both versatile and comprehensive.”

Present at event, Dr SK Sharma, Chairman, EKO X-Ray & Imaging Institute, “The thought behind HCG EKO collaboration is the common driving force of the two entities, which is to constantly upgrade the practice with aid of new and advanced technologies. Combining the two respective specialties, that is, diagnostic services by EKO and cancer treatment and care by HCG, the aim is to provide comprehensive facilities that cater the need for advanced cancer treatment and care all under one roof.”

Comments are closed.